您的位置：
首页
>
农业专利
>
详情页
SUBACUTE ADMINISTRATION OF NMDA MODULATORS ALONE OR IN COMBINATION
专利权人:
Northwestern University
发明人:
Joseph R. Moskal,Hebert Meltzer
申请号：
US15773084
公开号：
US20180325893A1
申请日:
2016.10.14
申请国别(地区):
US
年份:
2018
代理人:
摘要：
This disclosure features combinations of NMDA modulators and atypical antipsychotics. The disclosure provides for example, methods of treating schizophrenia, bipolar disorder, and/or cognitive impairment disorder in a patient in need thereof, comprising administering e.g., rapastinel and an atypical antipsychotic.
来源网站：
中国工程科技知识中心
来源网址：
http://www.ckcest.cn/home/
相关专利
COMBINAISON PHARMACEUTIQUE D'UN ANTIPSYCHOTIQUE ATYPIQUE ET D'UN MODULATEUR DE NMDA POUR LE TRAITEMENT DE LA SCHIZOPHRENIE, D'UN TROUBLE BIPOLAIRE, D'UN TROUBLE COGNITIF ET D'UN TROUBLE DEPRESSIF MAJEUR
Pharmaceutical combination of an atypical antipsychotic and an NMDA modulator for the treatment of schizophrenia,bipolar disorder, cognitive impairment and major depressive disorder
PHARMACEUTICAL COMBINATION OF Atypical Antipsychotic and NMDA Modulator for the Treatment of Schizophrenia, Bipolar Disorder, Cognitive Disorder and Clinical Depression
pharmaceutical combination of an atypical antipsychotic and an nmda modulator for the treatment of schizophrenia, bipolar disorder, cognitive impairment and major depressive disorder
Combination of atypical antipsychotics and NMDA modulators for the treatment of schizophrenia, bipolar disorder, cognitive impairment and major depressive disorder
